- Home
- ISTR vs ABOS Comparison
ISTR vs ABOS Comparison
Compare ISTR & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- ABOS
- Stock Information
- Founded
- ISTR 2006
- ABOS 1996
- Country
- ISTR United States
- ABOS United States
- Employees
- ISTR N/A
- ABOS N/A
- Industry
- ISTR Major Banks
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- ABOS Health Care
- Exchange
- ISTR Nasdaq
- ABOS Nasdaq
- Market Cap
- ISTR 225.8M
- ABOS 99.1M
- IPO Year
- ISTR 2014
- ABOS 2021
- Fundamental
- Price
- ISTR $19.65
- ABOS $1.56
- Analyst Decision
- ISTR
- ABOS Strong Buy
- Analyst Count
- ISTR 0
- ABOS 3
- Target Price
- ISTR N/A
- ABOS $9.33
- AVG Volume (30 Days)
- ISTR 30.9K
- ABOS 379.4K
- Earning Date
- ISTR 01-23-2025
- ABOS 11-12-2024
- Dividend Yield
- ISTR 2.10%
- ABOS N/A
- EPS Growth
- ISTR N/A
- ABOS N/A
- EPS
- ISTR 1.79
- ABOS N/A
- Revenue
- ISTR $82,729,000.00
- ABOS N/A
- Revenue This Year
- ISTR N/A
- ABOS N/A
- Revenue Next Year
- ISTR $12.80
- ABOS N/A
- P/E Ratio
- ISTR $10.92
- ABOS N/A
- Revenue Growth
- ISTR N/A
- ABOS N/A
- 52 Week Low
- ISTR $14.60
- ABOS $1.54
- 52 Week High
- ISTR $24.81
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- ISTR 33.30
- ABOS 30.29
- Support Level
- ISTR $18.50
- ABOS $1.69
- Resistance Level
- ISTR $22.39
- ABOS $1.88
- Average True Range (ATR)
- ISTR 0.64
- ABOS 0.13
- MACD
- ISTR -0.28
- ABOS -0.00
- Stochastic Oscillator
- ISTR 28.00
- ABOS 4.88
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.